TRCT
BIOC

Tower Research Capital (TRC)’s Biocept, Inc. BIOC Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,802
Closed -$4.75K – 6403
2023
Q3 		$4.75K Sell
3,802
-1,587
-29% -$1.91K ﹤0.01% 4815
2023
Q2 		$6.52K Buy
5,389
+5,110
+1,832% +$28.9K ﹤0.01% 4692
2023
Q1 		$3K Sell
279
-1
-0.4% -$14 ﹤0.01% 5292
2022
Q4 		$4K Sell
280
-17
-6% -$375 ﹤0.01% 5130
2022
Q3 		$8K Sell
297
-51
-15% -$1.51K ﹤0.01% 4846
2022
Q2 		$10K Buy
348
+295
+557% +$13.4K ﹤0.01% 4517
2022
Q1 		$4K Sell
53
-14
-21% -$1.1K ﹤0.01% 5304
2021
Q4 		$7K Buy
+67
New +$7.72K ﹤0.01% 4975
2016
Q1 		– Hold
0
– -$2K – 5166
2015
Q4 		– Hold
0
– – – 3851
2015
Q3 		– Hold
0
– – – 3715
2015
Q2 		– Sell
-1
Closed -$40K – 5203
2015
Q1 		$40K Buy
+1
New +$67.2K ﹤0.01% 1662
2014
Q4 		– Hold
0
– -$1K – 4876
2014
Q3 		– Hold
0
– – – 4196
2014
Q2 		– Hold
0
– – – 3263

Tower Research Capital (TRC)'s BIOC Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 3,802 shares — an estimated $4.75K sold.

Tower Research Capital (TRC) first reported a position in BIOC in Q1 2015 and held it in 9 quarters. The position peaked at $40K in Q1 2015. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,802 Biocept, Inc. shares in Q4 2023, an estimated $4.75K.
  • Tower Research Capital (TRC) first reported a position in Biocept, Inc. in Q1 2015 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s Biocept, Inc. position peaked at $40K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.